(Q41640265)

English

EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line

scientific article published on February 5, 1992

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733967

11 November 2022

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

author name string

M. C. Moroni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733967

11 November 2022

M. C. Willingham

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733967

11 November 2022

L. Beguinot

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733967

11 November 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

5 February 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1733967

11 November 2022

full work available at URL

http://intl.jbc.org/cgi/content/abstract/267/4/2714

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733967

11 November 2022

https://api.elsevier.com/content/article/PII:S0021925818459388?httpAccept=text/xml

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

https://api.elsevier.com/content/article/PII:S0021925818459388?httpAccept=text/plain

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

267

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

2714-2722

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

1

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Epidermal growth factor-dependent growth of human KB cells in a defined medium and altered growth factor requirements of KB mutants resistant to EGF-Pseudomonas exotoxin conjugates

2

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

4

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Suppression of human colorectal carcinoma cell growth by wild-type p53

5

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes

7

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors

8

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

10

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF

11

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo

13

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin

14

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

15

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Epidermal growth factor regulates the expression of its own receptor

16

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA

17

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Transforming growth factor alpha

18

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Cancer Research

19

47

707

author name string

Derynck

publication date

1987

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

20

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro

21

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

High Efficiency DNA-Mediated Transformation of Primate Cells

22

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

23

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Cooperation between oncogenes

27

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

28

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Raf-1 protein kinase is required for growth of induced NIH/3T3 cells

29

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro

30

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

32

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Cancer Research

33

47

2961

author name string

Lyall

publication date

1987

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Tumor suppressor genes

35

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Injected anti-sense RNAs specifically block messenger RNA translation in vivo

36

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

39

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Trans-activation by the c-myb proto-oncogene

41

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Overlapping positive and negative regulatory domains of the human beta-interferon gene

42

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18

43

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

44

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Epidermal growth factor receptors in non-small cell lung cancer

45

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene

46

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Retroviruses expressing different levels of the normal epidermal growth factor receptor: biological properties and new bioassay

48

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Cancer Research

49

48

3780

author name string

Von Knebel Doeberitz

publication date

1988

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Microinjection of anticlathrin antibodies into fibroblasts does not interfere with the receptor-mediated endocytosis of α2-macroglobulin

50

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression

51

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines

52

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors

53

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Cancer Research

54

46

414

author name string

Yamamoto

publication date

1986

1 reference

10.1016/S0021-9258(18)45938-8

https://api.crossref.org/works/10.1016/S0021-9258(18)45938-8

11 November 2022

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1733967%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41640265&oldid=2202084271"